Icometrix, a company specializing in analytic software for use with brain imaging, and Siemens Healthineers have announced a partnership to provide the Icometrix icobrain artifical intelligence technology for magnetic resonance imaging (MRI) through the Siemens Healthineers digital marketplace.
The icobrain portfolio offers artificial intelligence solutions to extract clinically meaningful data and metrics from brain scans to patients with neurological disorders such as multiple sclerosis, traumatic brain injury, and dementia. All products in this portfolio have received U.S. Food and Drug Administration (FDA) clearance and European Union CE Mark clearance.
The products of the Siemens Healthineers digital marketplace are designed to help increase decision making capabilities based on data-driven insights. This dedicated digital marketplace for customers in the European Union and the United States supports healthcare providers to efficiently assess, purchase, and deploy digital health software.
Siemens stated in a press release announcement that the company was supporting the objective assessment of neurological disease and to enhance its set of solutions in the area of image-based neurology.”Back To Top
Icometrix and Siemens to partner on AI solutions for brain MRIs. Appl Radiol.